Last reviewed · How we verify
DMSA
At a glance
| Generic name | DMSA |
|---|---|
| Also known as | Dimercaptosuccinic Acid |
| Sponsor | National Institute of Mental Health (NIMH) |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy (PHASE1)
- Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomized Study (PHASE2)
- Usefulness of White Blood Cell Count (WBCC) During Infection in Geriatric Patient
- The Validity of the Quick Renal MRI in Pediatric Kidney Disease (NA)
- Prediction of Renal Parenchymal Damage of CAKUT
- Simplification of Low Level Internal Dosimetry
- Biokinetics Study of Tc-99m DMSA in Pediatric Molecular Imaging
- Single Photon Emission Computed Tomography/Computed Tomography With Pentavalent 99mTc Dimercaptosuccinic Acid in Patients With Brain Glioma; Correlation With IDH Mutation
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |